Scott W. Cole
Expertise in
80
conditions

Dr. Scott W. Cole

Oncology
12697 E 51st St, 
Tulsa, OK 
Accepting New Patients
Offers Telehealth
Expertise in
80
conditions
12697 E 51st St, 
Tulsa, OK 

Overview

Scott W. Cole, MD, is a board-certified, independent hematologist, oncologist and hospice/palliative medicine specialist at Ascension St. John in Tulsa, Oklahoma. Dr. Cole diagnoses and treats blood diseases and blood cancer. Every appointment with Dr. Cole starts with a conversation. He takes the time to answer all your questions - big and small.

Dr. Cole is highly rated in 80 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome.

Dr. Cole is board certified in The American Board Of Internal Medicine - Hematology, The American Board Of Internal Medicine - Hospice And Palliative Medicine, and The American Board Of Internal Medicine - Medical Oncology. He is actively involved in clinical research, co-authoring 3 peer reviewed articles. Dr. Cole is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in AL

Board Certifications

The American Board Of Internal Medicine - Hematology
The American Board Of Internal Medicine - Hospice And Palliative Medicine
The American Board Of Internal Medicine - Medical Oncology

Fellowships

Medical Univ of South Carolina College of Medicine

Hospital Affiliations

Ascension St John Medical Center
Stillwater Medical Center
Saint Francis Hospital Vinita, Inc
Oklahoma State University Medical Center
Saint Francis Hospital, Inc
Ascension St. John Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
CommunityCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Oklahoma Cancer Specialist and Research Institute
12697 E 51st St, Tulsa, OK 74146

Additional Areas of Focus

Dr. Cole has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Total Publications

COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.
COMMIT: A Randomized Study of mFOLFOX6/Bevacizumab/Atezolizumab or Atezolizumab Alone as First-Line Treatment of Deficient DNA Mismatch Repair Metastatic Colorectal Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2026
Similar Doctors
Expertise in
101
conditions
Expertise in
101
conditions
Referral may be required

Oklahoma Cancer Specialist And Research Institute

12697 E 51st St, 
Tulsa, OK 
 (0.1 miles away)
918-505-3200
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Ali H. Moussa, MD, is a board-certified, independent oncologist with Ascension St. John in Tulsa, Oklahoma. Dr. Moussa diagnoses and treats cancer using medications, such as chemotherapy, immunotherapy and targeted therapies. Every appointment with Dr. Moussa starts with a conversation. He takes the time to answer all your questions - big and small. Dr. Moussa is highly rated in 101 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Moussa is board certified in The American Board Of Internal Medicine - Medical Oncology and The American Board Of Internal Medicine - Internal Medicine. Dr. Moussa is currently accepting new patients.

Expertise in
51
conditions
Expertise in
51
conditions
Referral may be required

Oklahoma Cancer Specialist And Research Institute

12697 E 51st St, 
Tulsa, OK 
 (0.1 miles away)
918-505-3200
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Charles W. Taylor, MD, is an independent medical oncologist at Ascension St. John in Tulsa, Oklahoma. Dr. Taylor diagnoses and treats cancer using medications, such as chemotherapy. Every appointment with Dr. Taylor starts with a conversation. He takes the time to answer all your questions - big and small. Dr. Taylor is highly rated in 51 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Taylor is board certified in The American Board Of Internal Medicine - Medical Oncology and The American Board Of Internal Medicine - Internal Medicine. Dr. Taylor is currently accepting new patients.

Expertise in
45
conditions
Dr. Jihad Khattab
Hematology | Oncology
Expertise in
45
conditions
Dr. Jihad Khattab
Hematology | Oncology
Referral may be required

Saint Francis Cancer Center

11212 East 48th Street, 
Tulsa, OK 
 (0.9 miles away)
918-556-3000
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Jihad Khattab is a Hematologist and an Oncologist practicing medicine in Tulsa, Oklahoma. Dr. Khattab is highly rated in 45 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Khattab is currently accepting new patients.

Frequently Asked Questions about Dr. Scott W. Cole

How do I make an appointment with Dr. Scott W. Cole?

You can book an appointment with Dr. Scott W. Cole by calling their office at 918-505-3200. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Scott W. Cole a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Scott W. Cole is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Scott W. Cole specialize in?

While Dr. Scott W. Cole is a Oncology, they have specific expertise in Paget Disease of the Breast, Familial Colorectal Cancer, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Scott W. Cole participate in research or clinical trials?

Yes. Dr. Scott W. Cole has published 3 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Scott W. Cole's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Scott W. Cole accept my insurance?

Dr. Scott W. Cole accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 918-505-3200 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Cole's expertise for a condition
ConditionClose
    View All 20 Distinguished Conditions
    View All 60 Advanced Conditions
    View All 93 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile